血管活性药物评分联合APACHE II评分对血流感染后脓毒性休克患者预后的预测价值
Prognostic Value of Vasoactive Inotropic Score Combined with APACHE II Score in Patients with Septic Shock after Bloodstream Infection
DOI: 10.12677/ACM.2024.142441, PDF,   
作者: 王佳权, 姚 莉*, 赵晶晶:安徽医科大学附属合肥医院(合肥市第二人民医院),重症医学科,安徽 合肥;安徽医科大学第五临床医学院,安徽 合肥
关键词: 血管活性药物评分脓毒性休克APACHE II评分病死率预测价值Vasoactive-Inotropic Score Septic Shock APACHE II Score Mortality Predictive Value
摘要: 目的:探讨血管活性药物评分(vasoactive inotropic score, VIS)联合急性生理与慢性健康评分(APACHE II)对血流感染后脓毒性休克患者结局的预测价值,为临床提供参考。方法:采用回顾性研究方法,通过收集2020年1月至2022年12月安徽医科大学附属合肥医院重症医学科收治的185例脓毒性休克患者的临床资料,根据28 d转归情况,分为存活组95例和死亡组90例,记录所有患者性别、年龄、相关血液检测指标、SOFA评分、24小时内急性生理与慢性健康评分(APACHE II)及24小时内最大血管活性药物评分(VISmax24)等信息,采用单因素分析筛选脓毒性休克患者的相关危险因素,多因素logistic回归分析影响脓毒性休克患者预后的独立危险因素,采用受试者工作特征(receiver op-erating characteristic, ROC)曲线下面积(area under curve, AUC)分析各指标的诊断价值。结果:单因素分析结果表明:死亡组的APACHE II评分(24.30 ± 5.157)、VISmax24 [100.0 (53.5, 121.0)]明显高于存活组(P < 0.05);多因素分析结果及ROC曲线下面积结果显示:VISmax24联合APACHE II评分(AUC = 0.848, 95% CI: 0.792~0.905),较单一的APACHE II评分(AUC = 0.729, 95% CI: 0.655~0.802)、VISmax24 (AUC = 0.783, 95% CI: 0.709~0.856)、乳酸(AUC = 0.665, 95% CI: 0.587~0.743)、SOFA (AUC = 0.680, 95% CI: 0.602~0.758)预测价值更高。结论:VISmax24联合APACHE II评分能更有效预测血流感染后脓毒性休克患者的预后。
Abstract: Objective: To study the predictive value of vasoactive-inotropic score (VIS) combined with acute physiology and chronic health evaluation (APACHE II) score for the outcome of patients with septic shock after the bloodstream infections, provide reference for clinical. Methods: A retrospective study was conducted to collect the clinical data of 185 patients with septic shock admitted to the Department of Intensive Care Medicine of Hefei Hospital Affiliated to Anhui Medical University from January 2020 to December 2022. According to the outcome of 28 days, 95 patients were divided in-to a survival group and 90 patients were divided into a death group. Gender, age, relevant blood test indicators, SOFA score, APACHE II score within 24 hours and the maximum vasoactive-inotropic score within 24 hours which were expressed as VISmax24 of all patients were recorded. Single factor analysis was used to screen the related risk factors of patients with septic shock. Multivariate lo-gistic regression was used to analyze the independent risk factors affecting the prognosis of patients with septic shock. The area under receiver operating characteristic curve was used to analyze the diagnostic value of each indicator. Results: Univariate analysis showed that APACHE II score (24.30 ± 5.157) and VISmax24 [100.0 (53.5, 121.0)] in the death group were significantly higher than those in the survival group (P < 0.05). The results of multi-factor analysis and the results of area under receiver operating characteristic curve showed that VISmax24 combined with APACHE II rating (AUC = 0.848, 95% CI: 0.792~0.905), compared with single APACHE II rating (AUC = 0.729, 95% CI: 0.655~0.802), VISmax24 (AUC = 0.783, 95% CI: 0.709~0.856), lactic acid (AUC = 0.665, 95% CI: 0.587~0.743), SOFA (AUC = 0.680, 95% CI: 0.602~0.758) had higher predictive value. Conclusion: VISmax24 combined with APACHE II score can predict the prognosis of patients with septic shock after bloodstream infection more effectively.
文章引用:王佳权, 姚莉, 赵晶晶. 血管活性药物评分联合APACHE II评分对血流感染后脓毒性休克患者预后的预测价值[J]. 临床医学进展, 2024, 14(2): 3114-3121. https://doi.org/10.12677/ACM.2024.142441

参考文献

[1] Seymour, C.W., Liu, V.X., Iwashyna, T.J., et al. (2016) Assessment of Clinical Criteria for Sepsis: For the Third Inter-national Consensus Definitions for Sepsis and Septic Shock (Sepsis-3). JAMA, 315, 762-774. [Google Scholar] [CrossRef] [PubMed]
[2] Annane, D., Aegerter, P., Jars-Guincestre, M.C., et al. (2003) Cur-rent Epidemiology of Septic Shock. American Journal of Respiratory and Critical Care Medicine, 168, 165-172. [Google Scholar] [CrossRef] [PubMed]
[3] Friedman, G., Silva, E. and Vincent, J.L. (1998) Has the Mortality of Septic Shock Changed with Time? Critical Care Medicine, 26, 2078-2086. [Google Scholar] [CrossRef] [PubMed]
[4] Angus, D.C., Linde-Zwirble, W.T., Lidicker, J., et al. (2001) Epidemiology of Severe Sepsis in the United States: Analysis of Incidence, Outcome, and Associated Costs of Care. Critical Care Medicine, 29, 1303-1310. [Google Scholar] [CrossRef] [PubMed]
[5] Corrêa, T.D., Vuda, M., Blaser, A.R., et al. (2012) Effect of Treatment Delay on Disease Severity and Need for Resuscitation in Porcine Fecal Peritonitis. Critical Care Medicine, 40, 2841-2849. [Google Scholar] [CrossRef
[6] Avni, T., Lador, A., Lev, S., et al. (2015) Vasopressors for the Treatment of Septic Shock: Systematic Review and Meta-Analysis. PLOS ONE, 10, e0129305. [Google Scholar] [CrossRef] [PubMed]
[7] Angus, D.C. (2019) How Best to Resuscitate Patients with Septic Shock? JAMA, 321, 647-648. [Google Scholar] [CrossRef] [PubMed]
[8] Brandt, S., Regueira, T., Bracht, H., et al. (2009) Effect of Fluid Resuscitation on Mortality and Organ Function in Experimental Sepsis Models. Critical Care, 13, R186. [Google Scholar] [CrossRef] [PubMed]
[9] Singer, M., Deutschmanc, C.S., Seymourc, C.W., et al. (2016) The Third In-ternational consensus Definitions for Sepsis and Septic Shock (Sepsis-3). JAMA, 315, 801-810. [Google Scholar] [CrossRef] [PubMed]
[10] Gaies, M.G., Gurney, J.G., Yen, A.H., et al. (2010) Vasoac-tive-Inotropic Score as a Predictor of Morbidity and Mortality in Infants after Cardiopulmonary Bypass. Pediatric Criti-cal Care Medicine, 11, 234-238. [Google Scholar] [CrossRef
[11] Garrouste-Orgeas, M., Timsit, J.F., Tafflet, M., et al. (2006) Excess Risk of Death from Intensive Care Unit-Acquired Nosocomial Blood-Stream Infections: A Reappraisal. Clinical Infectious Diseases, 42, 1118-1126. [Google Scholar] [CrossRef] [PubMed]
[12] Edda, V., Ingi, M.S., Magnus, G., et al. (2022) Temporal Trends in the Epi-demiology, Management and Outcome of Sepsis—A Nationwide Observational Study. Acta Anaesthesiologica Scandi-navica, 66, 497-506. [Google Scholar] [CrossRef] [PubMed]
[13] Munroe, E.S., Heath, M.E., Mousab, E., et al. (2023) Use and Outcomes of Peripheral Vasopressors in Early Sepsis-Induced Hypotension across Michigan Hospitals: A Retrospective Cohort Study. Chest, 12, No. 23.
[14] Gaies, M.G., Gurney, J.G., Yen, A.H., et al. (2010) Vasoactive-Inotropic Score as a Predictor of Morbidity and Mortality in Infants after Cardiopulmonary Bypass. Pediatric Critical Care Medicine, 11, 234-238. [Google Scholar] [CrossRef
[15] 李鹏飞, 陈齐齐, 蒋文, 等. 不同时间的血管活性药物评分对脓毒性休克患者死亡风险的预测价值[J]. 中华急诊医学杂志, 2021, 30(5): 582-587. [Google Scholar] [CrossRef
[16] 张越新, 张玲, 郭贤庆, 等. PCT CRP血乳酸APACHE II SOFA评分在脓毒症患者疾病严重程度及预后评估中的价值研究[J]. 中国急救医学, 2017, 37(12): 1109-1114. [Google Scholar] [CrossRef
[17] 周文杰, 张小亚, 张珺, 等. APACHE II和SOFA评分联合血清降钙素原对鲍曼不动杆菌血流感染患者预后的预测价值[J]. 中国急救医学, 2017, 37(3): 221-225. [Google Scholar] [CrossRef
[18] Śmiechowicz, J. (2015) Prognostic Scoring Systems for Mortality in Intensive Care Units: The APACHE Model. Anaesthesiology Intensive Therapy, 47, 87-88. [Google Scholar] [CrossRef
[19] 顾永辉, 卞叶萍, 林兆奋. APACHE II、SOFA评分及降钙素原水平对脓毒症严重度及预后的评估价值[J]. 医学与哲学(B), 2015, 36(12): 35-37.
[20] Bledsoe, B.E., Casey, M.J., Feldman, J., et al. (2015) Glasgow Coma Scale Scoring Is Often Inaccurate. Prehospital and Disaster Medicine, 30, 46-53. [Google Scholar] [CrossRef
[21] Lasocki, S., Pène, F., Ait-Oufella, H., et al. (2020) Management and Prevention of Anemia (Acute Bleeding Excluded) in Adult Critical Care Patients. Anaesthesia Critical Care & Pain Medicine, 39, 655-664. [Google Scholar] [CrossRef] [PubMed]